ENTITY
Hisamitsu Pharmaceutical Co

Hisamitsu Pharmaceutical Co (4530 JP)

86
Analysis
Health Care • Japan
HISAMITSU PHARMACEUTICAL CO., INC. produces and sells pharmaceutical products. The Company's main product is anti-inflammatory analgesic plasters and poultices sold under the brand name Salonpas. Hisamitsu Pharmaceutical exports its products to North America and Southeast Asia. The Company also researches and develops antibacterial products through its related company, RRF.
more
•29 Jan 2026 14:43

[Japan M&A] Hisamitsu (4530 JP) Continues To Trade Through the Price But Not A Great Bet IMO

Hisamitsu Pharma continues to trade through terms. It doesn't look like a good bet to me. I think they can get almost all the way there on their...

Logo
333 Views
Share
•11 Jan 2026 16:12

Weekly Deals Digest (11 Jan) - Hisamitsu, Pacific Ind, Sankei, Japan Infra Fund, Jinke, BlueScope

A weekly summary of key developments across ECM and Event-Driven names tracked by us across Hong Kong, Australia, NZ, Singapore, Japan, Indonesia,...

Logo
304 Views
Share
•08 Jan 2026 08:30

Hisamitsu Pharma (4530 JP): MBO at ¥6,082 Offers A Decent Exit Opportunity

​Hisamitsu Pharmaceutical Co announced MBO to go private at ¥6,082 per share. Given the fundamentals  the offer price seems a decent exit...

Logo
327 Views
Share
•07 Jan 2026 05:18

Hisamitsu Pharma (4530 JP): MBO at JPY6,082

The offer is attractive. The sheer number of irrevocables and the presence of several cross-holders will aid in deal completion.

Logo
455 Views
Share
•06 Jan 2026 19:33

Hisamitsu Pharma (4530 JP): An Imminent MBO at a Rumoured JPY450 Billion Valuation

Hisamitsu confirmed that it plans to announce an MBO today. An offer at the rumoured JPY450bn valuation is attractive compared to precedent...

Logo
491 Views
Share
x